NDC 72266-0101-01
Dexrazoxane for Injection 500 mg/50mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Available — 2-Day Shipping
NDC
72266-0101-01
Generic Name
Dexrazoxane for Injection
Brand Name
Dexrazoxane
Strength
500 mg/50mL
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Package Size
—
Labeler
Fosun Pharma USA Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Dexrazoxane for injection is indicated for reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg/m 2 and who will continue to receive doxorubicin therapy to maintain tumor control. Do not use with the initiation of doxorubicin therapy [see Warnings and Precautions ( 5.2 )] . Dexrazoxane for injection is a cytoprotective agent indicate…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Dexrazoxane for Injection Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other Dexrazoxane for Injection NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 72266-0101-01 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).